SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Price Chart
Latest Quote
$3.16
-0.39 (-10.99%)
Current Price
| Previous Close | $3.55 |
| Open | $3.40 |
| Day High | $3.40 |
| Day Low | $3.02 |
| Volume | 128,392 |
Stock Information
| Shares Outstanding | 585K |
| Total Debt | $214K |
| Cash Equivalents | $1.09M |
| Net Income | $-10.82M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.85M |
| P/E Ratio | 31.60 |
| EPS (TTM) | $0.10 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $973K |
| Income | $-10.82M |
| Book/sh | $6.03 |
| Cash/sh | $1.86 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 0.13 |
| Current Ratio | 0.30 |
| Debt/Eq | 6.40 |
Returns & Margins
| ROA | -81.65% |
| ROE | -326.36% |
Ownership
| Insider Ownership | 6.30% |
| Institutional Ownership | 3.38% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 0.52 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.49 |
| SMA50 | $4.74 |
| SMA200 | $14.73 |
| RSI | 40.69 |
| ATR | 0.6303 |
| Shares Float | 582K |
| Short Float | 23.76% |
| Short Ratio | 0.06 |
| Volatility | 1.29 |
| Rel Volume | 0.02 |
Performance History
| Week | +8.22% |
| Month | -22.55% |
| Quarter | -69.32% |
| 6 Months | -79.21% |
| YTD | -82.54% |
| Year | -91.92% |
| 3 Years | -99.85% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $3.16 | 128,392 |
| 2026-07-16 | $3.55 | 163,900 |
| 2026-07-15 | $3.65 | 958,700 |
| 2026-07-14 | $4.16 | 53,359,800 |
| 2026-07-13 | $2.96 | 19,753,700 |
| 2026-07-10 | $2.92 | 72,400 |
| 2026-07-09 | $3.28 | 130,900 |
| 2026-07-08 | $3.57 | 2,391,500 |
| 2026-07-07 | $3.26 | 110,800 |
| 2026-07-06 | $3.50 | 87,500 |
| 2026-07-02 | $3.58 | 196,400 |
| 2026-07-01 | $3.40 | 179,800 |
| 2026-06-30 | $3.25 | 146,600 |
| 2026-06-29 | $3.25 | 697,900 |
| 2026-06-26 | $4.02 | 31,587,600 |
| 2026-06-25 | $3.78 | 10,154,300 |
| 2026-06-24 | $3.69 | 66,400 |
| 2026-06-23 | $3.84 | 75,500 |
| 2026-06-22 | $3.52 | 44,500 |
| 2026-06-18 | $3.46 | 606,800 |
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
đ° Latest News
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today
Stocktwits âĸ 2026-06-26T01:33:26Z
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
CryptoProwl âĸ 2026-05-01T14:37:00Z
Shuttle Pharma Layers AI Into Its Big Oncology Push
Moby âĸ 2025-12-18T20:39:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $70,828 | $1,360,156 | $2,595,263 | $480,698 |
| Total Expenses | $11,916,824 | $7,696,170 | $5,892,382 | $2,343,826 |
| Other Income Expense | $264,893 | $-126,609 | $1,815,805 | $-1,981,633 |
| Other Non Operating Income Expenses | $-3,351 | $122,553 | - | $328,687 |
| Net Non Operating Interest Income Expense | $-69,738 | $-1,322,018 | $-2,516,146 | $-670,610 |
| Interest Expense Non Operating | $70,828 | $1,360,156 | $2,595,263 | $480,698 |
| Operating Expense | $11,916,824 | $7,696,170 | $5,892,382 | $2,343,826 |
| General And Administrative Expense | $7,861,993 | $4,077,374 | $2,375,289 | $1,296,441 |
| Total Other Finance Cost | - | - | $104,245 | $189,912 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Net Interest Income | $-69,738 | $-1,322,018 | $-2,516,146 | $-670,610 |
| Interest Income | $1,090 | $38,138 | $79,117 | $0 |
| Normalized Income | $-11,989,913 | $-8,895,635 | $-8,408,528 | $-3,014,436 |
| Net Income From Continuing And Discontinued Operation | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Total Operating Income As Reported | $-11,916,824 | $-7,696,170 | $-5,892,382 | $-2,343,826 |
| Net Income Common Stockholders | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-6,747,137 |
| Net Income | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Net Income Including Noncontrolling Interests | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Net Income Continuous Operations | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Pretax Income | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Special Income Charges | $342,650 | $-833,501 | $-477,221 | $-1,393,958 |
| Interest Income Non Operating | $1,090 | $38,138 | $79,117 | $0 |
| Operating Income | $-11,916,824 | $-7,696,170 | $-5,892,382 | $-2,343,826 |
| Per Share | ||||
| Diluted EPS | $-71.60 | $-826.00 | $-882.50 | $-1260.00 |
| Basic EPS | $-71.60 | $-796.50 | $-882.50 | $-1260.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,628,978 | $-7,530,016 | $-5,806,454 | $-2,527,766 |
| Total Unusual Items | $268,244 | $-249,162 | $1,815,805 | $-1,981,633 |
| Total Unusual Items Excluding Goodwill | $268,244 | $-249,162 | $1,815,805 | $-1,981,633 |
| Reconciled Depreciation | $290,107 | $5,463 | $6,811 | $5,972 |
| EBITDA (Bullshit earnings) | $-11,360,734 | $-7,779,178 | $-3,990,649 | $-4,509,399 |
| EBIT | $-11,650,841 | $-7,784,641 | $-3,997,460 | $-4,515,371 |
| Diluted Average Shares | $163,792 | $11,549 | $7,465 | $5,350 |
| Basic Average Shares | $163,792 | $11,480 | $7,465 | $5,350 |
| Diluted NI Availto Com Stockholders | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-6,747,137 |
| Other Special Charges | $-342,650 | $833,501 | $477,221 | $1,393,958 |
| Gain On Sale Of Security | $-74,406 | $584,339 | $2,293,026 | $-587,675 |
| Research And Development | $4,054,831 | $3,618,796 | $3,517,093 | $1,047,385 |
| Selling General And Administration | $7,861,993 | $4,077,374 | $2,375,289 | $1,296,441 |
| Other Gand A | $7,861,993 | $4,077,374 | $2,375,289 | $1,296,441 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $941,000 |
| Preferred Stock Dividends | - | - | - | $810,068 |
| Tax Provision | - | - | - | $0 |
| Write Off | - | - | - | - |
Fetched: 2026-07-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,586,796 | $709,152 | $4,055,771 | $7,677,869 |
| Total Assets | $10,475,977 | $2,506,290 | $5,951,736 | $8,653,545 |
| Total Non Current Assets | $9,973,066 | $295,373 | $358,731 | $75,194 |
| Non Current Deferred Assets | $12,122 | $0 | - | - |
| Goodwill And Other Intangible Assets | $9,841,242 | $0 | - | - |
| Other Intangible Assets | $9,841,242 | - | - | - |
| Current Assets | $502,911 | $2,210,917 | $5,593,005 | $8,578,351 |
| Other Current Assets | $1 | - | - | - |
| Prepaid Assets | $168,905 | $290,773 | $114,473 | $161,148 |
| Cash Cash Equivalents And Short Term Investments | $334,005 | $1,920,144 | $5,463,631 | $8,417,203 |
| Cash And Cash Equivalents | $334,005 | $1,920,144 | $2,576,416 | $8,417,203 |
| Cash Equivalents | $76,050 | $1,203 | $1,026,318 | $3,005,825 |
| Cash Financial | $257,955 | $1,918,941 | $1,550,098 | $5,411,378 |
| Receivables | - | $0 | $14,901 | $0 |
| Accrued Interest Receivable | - | $0 | $14,901 | $0 |
| Other Non Current Assets | - | - | - | $6,480 |
| Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $232,147 | $1,173,472 | $1,087,694 | $748,296 |
| Long Term Debt And Capital Lease Obligation | $154,953 | $238,088 | $439,216 | $0 |
| Current Debt And Capital Lease Obligation | $77,194 | $935,384 | $648,478 | $748,296 |
| Current Debt | - | $874,475 | $595,999 | $685,473 |
| Other Current Borrowings | - | $684,205 | $595,999 | - |
| Long Term Debt | - | - | $135,089 | - |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,221,531 | $1,797,138 | $1,895,965 | $975,676 |
| Total Non Current Liabilities Net Minority Interest | $254,640 | $263,369 | $853,728 | $0 |
| Derivative Product Liabilities | $99,687 | $25,281 | $414,512 | $0 |
| Current Liabilities | $7,966,891 | $1,533,769 | $1,042,237 | $975,676 |
| Other Current Liabilities | $2,000,000 | - | - | - |
| Current Notes Payable | $0 | $190,270 | $0 | $685,473 |
| Payables And Accrued Expenses | $5,889,697 | $598,385 | $393,759 | $227,380 |
| Interest Payable | $0 | $1,785 | $110,453 | $98,135 |
| Payables | $5,889,697 | $596,600 | $283,306 | $129,245 |
| Other Payable | $4,435,927 | - | - | - |
| Accounts Payable | $1,453,770 | $596,600 | $283,306 | $129,245 |
| Dividends Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $2,254,446 | $709,152 | $4,055,771 | $7,677,869 |
| Total Equity Gross Minority Interest | $2,254,446 | $709,152 | $4,055,771 | $7,677,869 |
| Stockholders Equity | $2,254,446 | $709,152 | $4,055,771 | $7,677,869 |
| Retained Earnings | $-46,299,770 | $-34,578,101 | $-25,433,304 | $-18,840,581 |
| Other Equity Interest | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $202,361 | $16,306 | $8,034 | $6,801 |
| Share Issued | $202,361 | $16,306 | $8,034 | $6,801 |
| Tangible Book Value | $-7,586,796 | $709,152 | $4,055,771 | $7,677,869 |
| Invested Capital | $2,254,446 | $1,583,627 | $4,786,859 | $8,363,342 |
| Working Capital | $-7,463,980 | $677,148 | $4,550,768 | $7,602,675 |
| Capital Lease Obligations | $232,147 | $298,997 | $356,606 | $62,823 |
| Total Capitalization | $2,254,446 | $709,152 | $4,190,860 | $7,677,869 |
| Additional Paid In Capital | $48,554,196 | $35,287,251 | $29,489,055 | $26,518,433 |
| Capital Stock | $20 | $2 | $20 | $17 |
| Common Stock | $20 | $2 | $20 | $17 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $154,953 | $238,088 | $304,127 | $0 |
| Current Capital Lease Obligation | $77,194 | $60,909 | $52,479 | $62,823 |
| Current Accrued Expenses | $0 | $1,785 | $110,453 | $98,135 |
| Net PPE | $119,702 | $295,373 | $358,731 | $68,714 |
| Gross PPE | $119,702 | $295,373 | $358,731 | $183,589 |
| Other Properties | $119,702 | $295,373 | $358,731 | $183,589 |
| Other Short Term Investments | - | $0 | $2,887,215 | $0 |
| Accumulated Depreciation | - | - | $-121,685 | $-114,875 |
| Machinery Furniture Equipment | - | - | - | $8,861 |
Fetched: 2026-07-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-12,538,367 | $-7,327,230 | $-5,600,193 | $-2,666,411 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,481,645 | $-7,327,230 | $-5,581,147 | $-2,666,411 |
| Cash Flow From Continuing Operating Activities | $-9,481,645 | $-7,327,230 | $-5,581,147 | $-2,666,411 |
| Operating Gains Losses | $417,056 | $249,162 | $-1,744,237 | $2,573,239 |
| Investing Activities | ||||
| Capital Expenditure | $-3,056,722 | - | $-19,046 | - |
| Investing Cash Flow | $-3,056,722 | $2,915,765 | $-2,829,723 | $0 |
| Cash Flow From Continuing Investing Activities | $-3,056,722 | $2,915,765 | $-2,829,723 | $0 |
| Capital Expenditure Reported | $-12,000 | $0 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $9,489,673 | $3,992,675 | $0 | $9,995,513 |
| Financing Cash Flow | $10,952,228 | $3,755,193 | $2,570,083 | $10,578,865 |
| Cash Flow From Continuing Financing Activities | $10,952,228 | $3,755,193 | $2,570,083 | $10,578,865 |
| Net Other Financing Charges | $-557,659 | $-264,184 | $-334,444 | $-17,363 |
| Cash Dividends Paid | $0 | $0 | - | - |
| Net Common Stock Issuance | $9,489,673 | $3,992,675 | $0 | $9,995,513 |
| Common Stock Issuance | $9,489,673 | $3,992,675 | $0 | $9,995,513 |
| Other | ||||
| Repayment Of Debt | $-190,270 | $-906,536 | $-685,473 | $-50,000 |
| Issuance Of Debt | $0 | $1,040,000 | $3,935,000 | $650,715 |
| Interest Paid Supplemental Data | $125,296 | $86,589 | $164,807 | $39,201 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $334,005 | $1,920,144 | $2,576,416 | $8,417,203 |
| Beginning Cash Position | $1,920,144 | $2,576,416 | $8,417,203 | $504,749 |
| Changes In Cash | $-1,586,139 | $-656,272 | $-5,840,787 | $7,912,454 |
| Interest Paid Cff | $-74,152 | $-107,491 | - | - |
| Proceeds From Stock Option Exercised | $2,284,636 | $729 | $-345,000 | - |
| Net Issuance Payments Of Debt | $-190,270 | $133,464 | $3,249,527 | $600,715 |
| Net Short Term Debt Issuance | $-190,270 | $133,464 | $-685,473 | $0 |
| Short Term Debt Payments | $-190,270 | $-906,536 | $-685,473 | $-50,000 |
| Short Term Debt Issuance | $0 | $1,040,000 | $0 | $50,000 |
| Net Investment Purchase And Sale | $0 | $2,915,765 | $-2,810,677 | $0 |
| Sale Of Investment | $0 | $2,959,352 | $187,895 | $0 |
| Purchase Of Investment | $0 | $-43,587 | $-2,998,572 | $0 |
| Net Intangibles Purchase And Sale | $-3,044,722 | $0 | - | - |
| Purchase Of Intangibles | $-3,044,722 | $0 | - | - |
| Interest Paid Cfo | $-115,339 | $0 | - | - |
| Change In Working Capital | $540,617 | $138,911 | $220,634 | $-462,790 |
| Change In Other Working Capital | $-2,459 | $286 | $16,001 | $-5,693 |
| Change In Other Current Assets | $0 | $0 | $6,480 | $0 |
| Change In Payables And Accrued Expense | $421,209 | $300,024 | $166,379 | $-300,815 |
| Change In Accrued Expense | $-1,785 | $-13,271 | $12,318 | $69,566 |
| Change In Interest Payable | $-1,785 | $-13,271 | $12,318 | $69,566 |
| Change In Payable | $422,994 | $313,295 | $154,061 | $-370,381 |
| Change In Account Payable | $422,994 | $313,295 | $154,061 | $-370,381 |
| Change In Prepaid Assets | $121,867 | $-176,300 | $46,675 | $-156,282 |
| Change In Receivables | $0 | $14,901 | $-14,901 | $0 |
| Other Non Cash Items | $62,030 | $1,286,840 | $2,417,976 | $-24,310 |
| Stock Based Compensation | $932,967 | $259,744 | $181,960 | $237,547 |
| Unrealized Gain Loss On Investment Securities | $3,351 | $-122,553 | $-71,568 | $0 |
| Asset Impairment Charge | $109,235 | $0 | - | - |
| Depreciation Amortization Depletion | $290,107 | $5,463 | $6,811 | $5,972 |
| Depreciation And Amortization | $290,107 | $5,463 | $6,811 | $5,972 |
| Depreciation | $290,107 | $5,463 | $6,811 | $5,972 |
| Gain Loss On Investment Securities | $74,406 | $-584,339 | $-2,221,458 | $777,587 |
| Net Income From Continuing Operations | $-11,721,669 | $-9,144,797 | $-6,592,723 | $-4,996,069 |
| Net Long Term Debt Issuance | - | $-56,806 | $3,935,000 | $600,715 |
| Long Term Debt Payments | - | $-846,806 | $0 | $0 |
| Long Term Debt Issuance | - | $790,000 | $3,935,000 | $600,715 |
| Net PPE Purchase And Sale | - | $0 | $-19,046 | $0 |
| Purchase Of PPE | - | $0 | $-19,046 | $0 |
| Change In Other Current Liabilities | - | - | - | $-66,553 |
| Changes In Account Receivables | - | - | - | $0 |
Fetched: 2026-07-17